Zenith Drugs IPO GMP Today ( Grey Market Premium )

Zenith Drugs IPO GMP Today ( Grey Market Premium )

The Zenith Drugs IPO commenced on February 19, 2024, and concluded on February 22, 2024. The allotment of shares took place on February 23, 2024, and the initiation of refunds began on February 26, 2024. The shares were credited to the demat accounts of investors on February 26, 2024. Finally, the listing of Zenith Drugs on the stock exchange occurred on February 27, 2024.

The Zenith Drugs IPO was priced at ₹75 to ₹79 per share, with a lot size of 1600 shares. The total issue size was ₹40.68 crores, comprising a fresh issue of 40.68 crores. The IPO was listed on the NSE SME.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.

Zenith Drugs IPO Basic Details

Company NameZenith Drugs Limited
Domain of CompanyPharma Company
Zenith Drugs IPO GMP Today₹7
Zenith Drugs IPO Listing Gain8.86%
Zenith Drugs IPO Open DateFebruary 19, 2024
Zenith Drugs IPO Close DateFebruary 22, 2024
Zenith Drugs IPO Allotment DateFebruary 23, 2024
Zenith Drugs IPO Listing DateFebruary 27, 2024
Face Value₹10 per share
Price₹75 to ₹79 per share
Lot Size1600 Shares
Issue Size5,148,800 shares of ₹10
(aggregating up to ₹40.68 Cr)
Fresh Issue5,148,800 shares of ₹10
(aggregating up to ₹40.68 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Company PromotersMr. Sandeep Bhardwaj,
Mr. Bhupesh Soni and
Mr. Ajay Singh Dassundi

Zenith Drugs IPO GMP Today:

DateGMPListing GainKostakSubject to
Today₹78.86%
16 February 2024₹78.86%

Zenith Drugs IPO Details:

Founded in the year 2000, Zenith Drugs Limited stands as a pharmaceutical company dedicated to producing and supplying high-quality and affordable medicines, including generic drugs.

We prioritize quality by adhering to WHO-GMP guidelines and obtaining ISO 9001:2015 certification from a reputable EuroUK certification body.

Our diverse product range encompasses ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. With the approval of over 600 products by the Food & Drugs Administration, 325 are actively in production.

Excitingly, we are currently establishing a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh, to enhance our production capabilities.

Our products reach various countries, including Costa Rica in Central America, the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.

Zenith Drugs Limited is a specialist in third-party manufacturing, also known as white label manufacturing. We proudly serve esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, Zest Pharma, and more.

As of March 31, 2023, our dedicated team comprises 89 employees, with 61 on payroll and 28 on contract.

Zenith Drugs IPO More Details Click Here

Zenith Drugs IPO FAQs

When is Zenith Drugs IPO open?

Zenith Drugs IPO will open on 19 February 2024.

When is Zenith Drugs IPO Close?

Zenith Drugs IPO will be closed on 22 February 2024.

What is Zenith Drugs IPO GMP Today?

The Zenith Drugs IPO GMP aka Grey Market Premium is ₹7.

What is Zenith Drugs IPO Kostak Rates Today?

The Zenith Drugs IPO Kostak Rate is ₹000.

What is Zenith Drugs IPO Subject to Sauda Price Today?

The Zenith Drugs IPO subject to sauda rates is ₹000.

Zenith Drugs IPO Expected Returns?

The Zenith Drugs expected return is 8.86%.

How much will be the listing gain in Zenith Drugs IPO?

Zenith Drugs IPO will get listing gain of 8.86%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *